Quantcast

Latest National Heart, Lung, and Blood Institute Stories

2011-07-22 10:53:00

ATLANTA, July 22, 2011 /PRNewswire-USNewswire/ -- The National Forum for Heart Disease and Stroke Prevention has offered to serve as the accountability partner to ensure that surveillance recommendations laid out in the Institute of Medicine's (IOM) report A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases, which was released to the public today, are implemented. The recommendations, which the IOM released in this report sponsored by the Centers for...

2011-07-05 06:00:00

MADISON, Wis., July 5, 2011 /PRNewswire/ -- The Medical College of Wisconsin (MCW) and Cellular Dynamics International (CDI) today announced receipt of a research grant award from the National Heart, Lung, and Blood Institute (NHLBI) to investigate the mechanisms underlying Left Ventricular Hypertrophy. Commonly known as an increase of the size and weight of the heart, Left Ventricular Hypertrophy is a common and major risk factor for heart disease and heart failure due to high blood...

b636c65c31fd06af473ad0b6327660cb
2011-05-27 08:25:00

U.S. government researchers said on Thursday that giving a high dose of niacin to people with heart disease who are already taking a cholesterol-lowering statin does nothing more to prevent heart attacks and strokes. The findings challenge the notion that raising high-density lipoprotein (HDL) can further reduce heart risks in people who already have their low-density lipoprotein (LDL) under control. Patients in the study who had a history of heart disease were treated with Abbott...

2011-05-26 00:00:28

Fellow to work with renowned researcher Dr. Richard Childs at NHLBI Bethesda, MD (PRWEB) May 25, 2011 The Foundation for the National Institutes of Health (FNIH) is pleased to announce today that Quinn Weisman has been awarded the first Rancic-O'Neill Fellowship, made possible by a partnership between the Dr. Edward T. Rancic Memorial Fund and the Dean R. O'Neill Renal Cell Cancer Fund, in support of research for renal cell carcinoma - or kidney cancer - at the National Institutes of Health...

2011-05-02 07:03:00

MILFORD, Mass., May 2, 2011 /PRNewswire/ -- SeraCare Life Sciences announced today that the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has awarded a new contract to SeraCare, replacing the current contract which expired on April 30, 2011. Under this contract, SeraCare, at the direction of the NHLBI, will advise on proper collection, processing and storage for biorepository collections. SeraCare will also continue to acquire, store and distribute...

2011-04-21 11:36:45

NIH-funded genome study could lead to increased knowledge of lung-scarring diseases Scientists funded by the National Institutes of Health have identified a common genetic variant associated with substantially increased risk of developing pulmonary fibrosis, a debilitating and life-threatening lung condition. The genetic variant is found in a region of DNA thought to regulate the production of an important mucus-forming protein. However, knowing the gene variant is not, by itself, enough for...

2011-04-15 14:29:03

Medical literature addresses possible adverse effects with older red cells; delivery of oxygen In light of recent studies that suggest the use of stored blood during transfusions may cause adverse effects in patients, the National Heart, Lung, and Blood Institute (NHLBI) funded a number of research projects to examine the safety of transfusing older red cells and the impact of stored blood on respiratory gases. These papers discussing potential adverse effects of stored blood and related...

2011-04-14 12:37:00

SAN DIEGO, April 14, 2011 /PRNewswire/ -- Promising new devices for mechanical circulatory support of children with heart defects or heart failure, and related research, will be revealed this week at the International Society for Heart and Lung Transplantation (ISHLT) 31st Annual Meeting and Scientific Sessions. An update from the Pumps for Kids, Infants and Neonates (PumpKIN) Program will be presented during the Meeting in San Diego. PumpKIN is supported by the National Heart, Lung, and...

2011-03-17 12:29:02

WHAT: Sirolimus, a drug currently used to help prevent transplant rejection, can improve lung function and quality of life in individuals living with the lung disease lymphangioleiomyomatosis (LAM), according to the results of a new study sponsored and conducted in part by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. "Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis," will be published online March 16 in the New England Journal of...

2011-03-09 14:42:33

NIH researchers present work today at Biophysical Meeting in Baltimore Researchers have created the first mouse models of human MYH9 genetic disorders, which cause several problems -- including enlarged platelets and sometimes fatal kidney disease. The MYH9 gene makes non-muscle myosin II-A protein. This protein plays a critical role in helping cells move to their correct home during embryonic development. Later in life, the protein continues its involvement in cell migration, cell-cell...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related